Evaluation of the biochemical, inflammatory and oxidative profile of obese patients given clinical treatment and bariatric surgery

Clinica Chimica Acta

Volumn 465, Issue , 2017, Pages 72-79

  Bitencourt, Mariana R ^a   Patias, Luciana D ^a   Beck, Maristela ^a   da C Alvarez, Glauco ^a   Diehl, Lia Natália ^a   Duarte, Marta Frescura ^a   Schetinger, Maria Rosa ^a   Morsch, Vera Maria ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b INSTITUTO FEDERAL DE EDUCAÇÃO   (Brazil)

Author keywords

Bariatric surgery; Clinical treatment; Inflammatory; Metabolism; Morbid obesity; Oxidative stress

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; CARBONYL DERIVATIVE; CATALASE; GHRELIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; RESTIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR; CYTOKINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BARIATRIC SURGERY; BIOCHEMICAL ANALYSIS; BODY MASS; BODY WEIGHT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIPID ANALYSIS; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DETERMINATION; ROUX-EN-Y GASTRIC BYPASS; WAIST CIRCUMFERENCE; BLOOD; COMPLICATION; GASTRIC BYPASS SURGERY; METABOLISM; MIDDLE AGED; OBESITY, MORBID; PROCEDURES; TREATMENT OUTCOME;

ADULT; CATALASE; CHOLESTEROL, HDL; CYTOKINES; DIABETES MELLITUS; FEMALE; GASTRIC BYPASS; HUMANS; INFLAMMATION; LIPID PEROXIDATION; MALE; MIDDLE AGED; OBESITY, MORBID; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME;

EID: 85007284410     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2016.12.012     Document Type: Article

References (59)

1. [1] World Health Organization Media Centre, Obesity and Overweight. Geneva, Switzerland, 2013.
2. [2] Centers for Disease Control and Prevention, Overweight and Obesity 2012. http://www.cdc.gov/obesity/adult/causes/index.html, 2013.
3. [3] Vanecková, I., Maletínská, L., Behuliak, M., Nagelová, V., Zicha, J., Kuneš, J., Obesity-related hypertension: possible pathophysiological mechanisms. J. Endocrinol. 223:3 (2014), 63–78.
4. [4] Instituto Brasileiro de Geografia e Estatística (IBGE), Antropometria e estado nutricional de crianças, adolescentes e adultos no Brasil. Disponível em http://www.ibge.gov.br, 2010.
5. [5] Nash, A., Secker, D., Corey, M., Dunn, M., O'Connor, D.L., Field testing of the 2006 World Health Organization growth charts from birth to 2 years: assessment of hospital under nutrition and overnutrition rates and the use fulness of BMI. J. Parenter. Enter. Nutr. 32 (2008), 145–153.
6. [6] Mittelman, S., Bergman, R., Central role of the adipocyte in insulin resistance. J. Basic Clin. Physiol. Pharmacol. 9 (1998), 205–221.
7. [7] Mazurek, T., Zhang, L., Zalewski, A., Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108 (2003), 2460–2466.
8. [8] Lau, D., Dhillon, B., Yan, H., Szmitko, P., Verma, S., Adipokines: molecular links between obesity and atherosclerosis. Am. J. Physiol. Heart Circ. Physiol. 288 (2005), 2031–2041.
9. [9] Lau, D., Yan, H., Abdel-Hafez, M., Kermouni, A., Adipokines and the paracrine control of their production in obesity and diabetes. Int. J. Obes. Relat. Metab. Disord., 26, 2002, 111.
10. [10] Matthew, P., Kate, J.C., Mohsen, M., Adipose dysfunction, interaction of reactive oxygen species, and inflammation. American Society for Nutrition Adv. Nutr. 3 (2012), 734–735.
11. [11] Sánchez, A.F., Madrigal-Santillán, E., Bautista, M., Esquivel-Soto, J., Morales-González, Á., Esquivel-Chirino, C., Durante-Montiel, I., Valadez-Vega, C., Sánchez-Rivera, G., Morales-González, J.Á., Inflammation, oxidative stress, and obesity. Int. J. Mol. Sci. 12 (2011), 3117–3132.
12. [12] Chrysohoou, C., Panagiotakos, D.B., Pitsavos, C., Skoumas, I., Papademetriou, L., Economou, M., Stefanadis, C., The implication of obesity on total antioxidant capacity apparently healthy men and women: the ATTICA study. Nutr. Metab. Cardiovasc. Dis. 17 (2007), 590–597.
13. [13] Olusi, S.O., Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int. J. Obes. 26 (2002), 1159–1164.
14. [14] Dandona, P., Mohanty, P., Ghanim, H., The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J. Clin. Endocrinol. Metab. 86 (2001), 355–362.
15. [15] Colquitt, J.L., Pickett, K., Loveman, E., Frampton, G.K., Surgery for weight loss in adults. Cochrane Database Syst. Rev. 8:8 (2014), 1620–1629.
16. [16] Bult, M.J.F., van Dalen, T., Muller, A.F., Surgical treatment of obesity. Eur. J. Endocrinol. 158 (2008), 135–145.
17. [17] Picot, J., Jones, J., Colquitt, J.L., Gospodarevskaya, E., Loveman, E., Baxter, L., Clegg, A.J., The clinical effectiveness and cost-effectivenessof bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol. 13 (2009), 215–357.
18. [18] Health Quality Ontario, Bariatric surgery for people with diabetes and morbid obesity: an evidence-based analysis. Ont. Health Technol. Assess. Ser. 9 (2009), 1–23.
19. [19] de la Cruz-Muñoz, N., Messiah, S.E., Arheart, K.L., Lopez-Mitnik, G., Lipshultz, S.E., Livingstone, A., Bariatric surgery significantly decreases the prevalence of type 2 diabetes mellitus and pre-diabetes among morbidly obese multiethnic adults: long-term results. J. Am. Coll. Surg. 212 (2011), 505–511.
20. [20] Friedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972), 499–502.
21. [21] Jentzsch, A.M., Bachmann, H., Furst, P., Biesalski, H.K., Improved analysis of malondialdehyde in human body fluids. Free Radic. Biol. Med. 20 (1996), 251–256.
22. [22] Levini, R.L., Garland, D., Oliver, C.N., Amici, A., Climent, I., Lenz, A., Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186 (1990), 464–478.
23. [23] Misra, H.P., Fridovich, I., The role of superoxide anion in autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247 (1972), 3170–3175.
24. 2 solutions in the UV). Anal. Biochem. 49 (1972), 474–478.
25. [25] Ellman, G.L., Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82 (1959), 70–77.
26. [26] Hager, G.R., van Haeten, T.W., Visseren, F.L.J., Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur. Heart J. 29 (2008), 2959–2971.
27. [27] Murri, M., García-Fuentes, E., García-Almeida, J.M., Garrido-Sánchez, L., Mayas, M.D., Bernal, R., Tinahones, F.J., Changes in oxidative stress and insulin resistance in morbidly obese patients after bariatric surgery. Obes. Surg. 20 (2010), 363–368.
28. [28] Illán-Gómez, F., Gonzálvez-Ortega, M., Orea-Soler, I., Alcaraz-Tafalla, M.S., Aragón-Alonso, A., Pascual-Díaz, M., Pérez-Paredes, M., Lozano-Almela, M.L., Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes. Surg. 22 (2012), 950–955.
29. [29] Sandoval, D., Bariatric surgeries: beyond restriction and malabsorption. Int. J. Obes. 35 (2011), S45–S49.
30. [30] Karra, E., Yousseif, A., Batterham, R.L., Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery. Trends Endocrinol. Metab. 21 (2010), 337–344.
31. [31] Cummings, D.E., Weigle, D.S., Frayo, R.S., Breen, P.A., Ma, M.K., Dellinger, E.P., Purnell, J.Q., Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 346 (2002), 1623–1630.
32. [32] Campos, S.P., Torrinhas, R.S., Giannella-Neto, D., Linetzky Waitzberg, D., Relationship between gut hormones and glucose homeostasis after bariatric surgery. Diabetol. Metab. Syndr., 6, 2014, 87.
33. [33] Meneghini, L.F., Impact of bariatric surgery on type 2 diabetes. Cell Biochem. Biophys. 48 (2007), 97–102.
34. [34] Vetter, M.L., Cardillo, S., Rickels, M.R., Iqbal, N., Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann. Intern. Med. 150 (2009), 94–103.
35. [35] Garcia-Marirrodriga, I., Amaya-Romero, C., Ruiz-Diaz, G.P., Férnandez, S., Ballesta-López, C., Pou, J.M., Romeo, J.H., Vilahur, G., Badimon, L., Ybarra, J., Evolution of lipid profiles after bariatric surgery. Obes. Surg. 22 (2012), 609–616.
36. [36] Jamal, M., Wegner, R., Heitshusen, D., Liao, J., Samuel, I., Resolution of hyperlipidemia follows surgical weight loss in patients undergoing Roux-en-Y gastric bypass surgery: a 6-year analysis of data. Surg. Obes. Relat. Dis. 7 (2011), 473–479.
37. [37] Victoria, J., Vieira-Potter, L., Inflammation and macrophage modulation in adipose tissues. Cell. Microbiol. 16 (2014), 1484–1492.
38. [38] Vendrell, J., Broch, M., Vilarrasa, N., Molina, A., Gómez, J.M., Gutiérrez, C., Simón, I., Sole, J., Richart, C., Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes. Res. 12 (2004), 962–971.
39. [39] Codoñer-Franch, P., Alonso-Iglesias, E., Resistin: insulin resistance to malignancy. Clin. Chim. Acta 13 (2014), 46–54.
40. [40] Edwards, C., Hindle, A.K., Fu, S., Brody, F., Downregulation of leptin and resistin expression in blood following bariatric surgery. Surg. Endosc. 25 (2010), 1962–1968.
41. [41] Jankiewicz-Wika, J., Kolomecki, K., Cywinski, J., Piestrzeniewicz, K., Swietoslawski, J., Stepien, H., Impact of vertical banded gastroplasty on body weight, insulin resistance, adipocytokine, inflammation and metabolic syndrome markers in morbidly obese patients. Endokrynol. Pol. 62 (2011), 109–119.
42. [42] Goktas, Z., Moustaid-Moussa, N., Chwan-Li, S., Boylan, M., Mo, H., Wang, S., Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance. Front. Endocrinol. 4 (2013), 69–84 Lausanne.
43. [43] Rao, S.R., Inflammatory markers and bariatric surgery: a meta-analysis. Inflamm. Res. 61 (2012), 789–807.
44. [44] Zeyda, M., Stulnig, T.M., Obesity, inflammation, and insulin resistance-a mini-review. Gerontology 55 (2009), 379–386.
45. [45] Rabe, K., Lehrke, M., Parhofer, K.G., Broedl, U.C., Adipokines and insulin resistance. Mol. Med. 14 (2008), 741–751.
46. [46] Cabrera, E.J., Valezi, A.C., Delfino, V.D.A., Lavado, E.L., Barbosa, D.S., Reduction in plasma levels of inflammatory and oxidative stress indicators after Roux-En-Y gastric bypass. Obes. Surg. 20 (2010), 42–49.
47. [47] Fantuzzi, G., Adiponectin and inflammation: consensus and controversy. J. Allergy Clin. Immunol. 121 (2008), 326–330.
48. [48] Filkova, M., Haluzik, M., Gay, S., Senolt, L., The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin. Immunol. 24 (2009), 133–157.
49. [49] Okamoto, Y., Kihara, S., Ouchi, N., Nishida, M., Arita, Y., Kumada, M., Ohashi, K., Sakai, N., Shimomura, I., Kobayashi, H., Terasaka, N., Inaba, T., Funahashi, T., Matsuzawa, Y., Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106 (2002), 2767–2770.
50. [50] Omae, T., Nagaoka, T., Tanano, I., Yoshida, A., Adiponectin-induced dilation of isolated porcine retinal arterioles via production of nitric oxide from endothelial cells. Invest. Ophthalmol. Vis. Sci. 54 (2013), 4586–4594.
51. [51] Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., Murakami, K., Ohteki, T., Uchida, S., Takekawa, S., Waki, H., Tsuno, N.H., Shibata, Y., Terauchi, Y., Froguel, P., Tobe, K., Koyasu, S., Taira, K., Kitamura, T., Shimizu, T., Nagai, R., Kadowaki, T., Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423 (2003), 762–769.
52. [52] Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., Eto, K., Akanuma, Y., Froguel, P., Foufelle, F., Ferre, P., Carling, D., Kimura, S., Nagai, R., Kahn, B.B., Kadowaki, T., Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8 (2002), 1288–1295.
53. [53] Sewon, L., Kwak, B.H., Role of adiponectin in metabolic and cardiovascular disease. J. Exerc. Rehabil. 10 (2014), 54–59.
54. [54] Boesing, F., Moreira, E.A., Wilhelm-Filho, D., Vigil, S.V., Parizottto, E.B., Inácio, D.B., Portari, G.V., Trindade, E.B., Jordão-Júnior, A.A., Fröde, T.S., Roux-en-Y bypass gastroplasty: markers of oxidative stress 6 months after surgery. Obes. Surg. 20 (2010), 1236–1944.
55. [55] Dadalt, C., Fagundes, R.L., Moreira, E.A., Wilhelm-Filho, D., de Freitas, M.B., Jordão Júnior, A.A., Biscaro, F., Pedrosa, R.C., Vannucchi, H., Oxidative stress markers in adults 2 years after Roux-en-Y gastric bypass. Eur. J. Gastroenterol. Hepatol. 25 (2013), 580–586.
56. [56] Gletsu-Miller, N., Hansen, J.M., Jones, D.P., Young-Mi, G., Torres, W.E., Ziegler, T.R., Lin, E., Loss of total and visceral adipose tissue mass predicts decreases in oxidative stress after weight loss surgery. Obesity 17 (2009), 439–446.
57. [57] Melissas, J., Malliaraki, N., Papadakis, J.A., Plasma antioxidant capacity in morbidly obese patients before and after weight loss. Obes. Surg. 16 (2006), 314–320.
58. [58] Sigfrid, L.A., Cytokines and nitric oxide inhibit the enzyme activity of catalase but not its protein or mRNA expression in insulin-producing cells. J. Mol. Endocrinol. 31 (2003), 509–518.
59. [59] Uzun, H., Konukoglu, D., Gelisgen, R., Plasma protein carbonyl and thiol stress before and after laparoscopic gastric banding in morbidly obese patients. Obes. Surg., 17, 2007, 1367.